Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000899243-21-021642

Options or other derivatives

  • Chief Scientific Officer acquired 110,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Beskrovnaya Oxana · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-02 Grant or award : show line 1 in the form Stock Option (right to buy) +110,000 110,000 D
Loading xslF345X03/doc4.xml…